By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

EPIRUS Biopharmaceuticals 

699 Boylston Street
11th Floor
Boston  Massachusetts   02116  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
EPIRUS Biopharmaceuticals Seeks British Columbia Securities Commission Order That It Is No Longer A Reporting Issuer 12/12/2014 10:52:04 AM
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014 11:30:15 AM
Data From EPIRUS Biopharmaceuticals’ Phase 3 Study Of BOW015, A Biosimilar Infliximab, To Be Presented As A Late Breaking Poster At American College of Rheumatology Annual Meeting 11/17/2014 5:18:03 PM
EPIRUS Biopharmaceuticals Reports Third Quarter Results And Provides Corporate Update 11/11/2014 9:15:12 AM
EPIRUS Biopharmaceuticals And Livzon Mabpharm Enter Collaboration Agreement For China 9/25/2014 10:08:34 AM
EPIRUS Biopharmaceuticals Announces Positive 58 Week Follow Up Data For BOW015 For Treatment Of Rheumatoid Arthritis 9/23/2014 10:40:47 AM
EPIRUS Biopharmaceuticals To Present At NewsMakers In The Biotech Industry Conference 9/22/2014 9:25:53 AM
EPIRUS Biopharmaceuticals To Present At Wedbush Life Sciences Management Access Conference 8/8/2014 9:18:35 AM
Mark H.N. Corrigan, M.D., Julie H. McHugh, And William Hunter, M.D. To Serve On EPIRUS Biopharmaceuticals Board Of Directors 7/15/2014 11:25:47 AM
EPIRUS Biopharmaceuticals And Zalicus Inc. (ZLCS) Complete Merger - Combined Company Will Trade As EPIRUS Biopharmaceuticals 7/15/2014 10:46:32 AM
12
//-->